
Mapping the Mysteries: Genetic Testing for Malan Overgrowth Syndrome
Excessive growth, intellectual disability and distinctive facial features follow mutations in the NFIX gene; testing distinguishes MOS from Sotos syndrome.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Excessive growth, intellectual disability and distinctive facial features follow mutations in the NFIX gene; testing distinguishes MOS from Sotos syndrome.

Underdeveloped jawbones, sensorineural hearing loss and signs of early aging follow POLD1 mutations, and testing separates MDPL from other progeroid syndromes.

Explore how genetic testing reveals the mysteries of MEGF8-related Carpenter syndrome, aiding in early diagnosis, personalized care, and family planning strategies.

IL12B encodes part of interleukin-12, needed to turn naive T cells into Th1 cells; without it, weakly pathogenic mycobacteria cause repeated infections.

Loss of IL12RB1 disrupts IL-12 and IL-23 signaling, leaving severe recurrent mycobacterial infections in an autosomal recessive pattern confirmed by gene testing.

When IRF8 works only partly, defense against Mycobacterium tuberculosis and non-tuberculous mycobacteria falters, and sequencing sets it apart from lookalikes.

Impaired STAT1 signaling leaves people vulnerable to mycobacteria that rarely trouble others, and a confirmed mutation shapes antimicrobial treatment plans.

Whole-exome sequencing identified somatic IDH1 mutations in metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria, a rare disorder of bone growth and metabolism.